Genome-wide association analysis of blood biomarkers in chronic obstructive pulmonary disease.
暂无分享,去创建一个
T. Beaty | E. Silverman | J. Crapo | A. Gulsvik | B. Celli | J. Vestbo | P. Bakke | J. Riley | D. Kim | M. Cho | C. Hersh | D. Lomas | B. Miller | X. Kong | A. Agustí | E. Wouters | H. Coxson | W. MacNee | J. Yates | S. Rennard | A. Litonjua | W. Qiu | R. Tal-Singer | W. Macnee | Xiangyang Kong
[1] P. Monaci,et al. Synergistic trans‐activation of the human C‐reactive protein promoter by transcription factor HNF‐1 binding at two distinct sites. , 1990, The EMBO journal.
[2] S. Steinberg,et al. Clara cell 10 kDa protein mRNA in normal and atypical regions of human respiratory epithelium , 1994, International journal of cancer.
[3] P. Burton,et al. Association between plasma CC16 levels, the A38G polymorphism, and asthma. , 2000, American journal of respiratory and critical care medicine.
[4] C. Hermans,et al. Clara Cell Secretory Protein (CC16): Features as a Peripheral Lung Biomarker , 2000, Annals of the New York Academy of Sciences.
[5] R. Pauwels,et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. , 2001, American journal of respiratory and critical care medicine.
[6] B. Ghosh,et al. Association of an intragenic microsatellite marker in the CC16 gene with asthma in the Indian population , 2004, Journal of Human Genetics.
[7] A. Jemal,et al. Trends in the leading causes of death in the United States, 1970-2002. , 2005, JAMA.
[8] P. Ridker,et al. Justification for the Use of Statins in Primary Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER)--can C-reactive protein be used to target statin therapy in primary prevention? , 2006, The American journal of cardiology.
[9] D. Reich,et al. Principal components analysis corrects for stratification in genome-wide association studies , 2006, Nature Genetics.
[10] T. Sørensen,et al. Surfactant Protein D of the Innate Immune Defence is Inversely Associated with Human Obesity and SP‐D Deficiency Infers Increased Body Weight in Mice , 2006, Scandinavian journal of immunology.
[11] G. Canonica,et al. Clara cell 16 protein in COPD sputum: a marker of small airways damage? , 2007, Respiratory medicine.
[12] E. Silverman,et al. The SERPINE2 gene is associated with chronic obstructive pulmonary disease. , 2006, American Journal of Human Genetics.
[13] A. Agustí. Systemic effects of chronic obstructive pulmonary disease: what we know and what we don't know (but should). , 2007, Proceedings of the American Thoracic Society.
[14] W. MacNee,et al. Evaluation of COPD Longitudinally to Identify Predictive Surrogate End-points (ECLIPSE) , 2008, European Respiratory Journal.
[15] Jacques Fellay,et al. WGAViewer: software for genomic annotation of whole genome association studies. , 2008, Genome research.
[16] Wentian Li,et al. Genome-Wide Association Scan Identifies Candidate Polymorphisms Associated with Differential Response to Anti-TNF Treatment in Rheumatoid Arthritis , 2008, Molecular medicine.
[17] Børge G Nordestgaard,et al. Genetically elevated C-reactive protein and ischemic vascular disease. , 2008, The New England journal of medicine.
[18] J. Dreiher,et al. Psoriasis and chronic obstructive pulmonary disease: a case–control study , 2008, The British journal of dermatology.
[19] M. Rieder,et al. Polymorphisms of the HNF1A gene encoding hepatocyte nuclear factor-1 alpha are associated with C-reactive protein. , 2008, American journal of human genetics.
[20] L. Edwards,et al. Evaluation of serum CC-16 as a biomarker for COPD in the ECLIPSE cohort , 2008, Thorax.
[21] F. Karadağ,et al. Biomarkers of Systemic Inflammation in Stable and Exacerbation Phases of COPD , 2008, Lung.
[22] E. Boerwinkle,et al. Identification of a urate transporter, ABCG2, with a common functional polymorphism causing gout , 2009, Proceedings of the National Academy of Sciences.
[23] P. Paré,et al. Associations of IL6 polymorphisms with lung function decline and COPD , 2009, Thorax.
[24] C. Carlson,et al. Common Coding Variants of the HNF1A Gene Are Associated With Multiple Cardiovascular Risk Phenotypes in Community-Based Samples of Younger and Older European-American Adults: The Coronary Artery Risk Development in Young Adults Study and The Cardiovascular Health Study , 2009, Circulation. Cardiovascular genetics.
[25] K. Shianna,et al. A Genome-Wide Association Study in Chronic Obstructive Pulmonary Disease (COPD): Identification of Two Major Susceptibility Loci , 2009, PLoS genetics.
[26] David C. Wilson,et al. Diverse genome-wide association studies associate the IL12/IL23 pathway with Crohn Disease. , 2009, American journal of human genetics.
[27] C. Gieger,et al. Association of Novel Genetic Loci With Circulating Fibrinogen Levels: A Genome-Wide Association Study in 6 Population-Based Cohorts , 2009, Circulation. Cardiovascular genetics.
[28] L. Edwards,et al. Serum surfactant protein D is steroid sensitive and associated with exacerbations of COPD , 2009, European Respiratory Journal.
[29] Edwin K Silverman,et al. Transforming growth factor-beta receptor-3 is associated with pulmonary emphysema. , 2009, American journal of respiratory cell and molecular biology.
[30] W. Naumnik,et al. Concentration of surfactant protein D, Clara cell protein CC-16 and IL-10 in bronchoalveolar lavage (BAL) in patients with sarcoidosis, hypersensivity pneumonitis and idiopathic pulmonary fibrosis. , 2009, Folia histochemica et cytobiologica.
[31] Ruth Tal-Singer,et al. Sputum neutrophils as a biomarker in COPD: findings from the ECLIPSE study , 2010, Respiratory research.
[32] Christoph Lange,et al. Variants in FAM13A are associated with chronic obstructive pulmonary disease , 2010, Nature Genetics.
[33] Michael Boehnke,et al. LocusZoom: regional visualization of genome-wide association scan results , 2010, Bioinform..
[34] J. Soriano,et al. Systemic inflammation in chronic obstructive pulmonary disease: a population-based study , 2010, Respiratory research.
[35] E. Regan,et al. Genetic Epidemiology of COPD (COPDGene) Study Design , 2011, COPD.
[36] R. Bowler,et al. Smoking reduces surfactant protein D and phospholipids in patients with and without chronic obstructive pulmonary disease , 2010, BMC pulmonary medicine.
[37] H. Coon,et al. Multistudy fine mapping of chromosome 2q identifies XRCC5 as a chronic obstructive pulmonary disease susceptibility gene. , 2010, American journal of respiratory and critical care medicine.
[38] J. Danesh,et al. Triglyceride-mediated pathways and coronary disease: collaborative analysis of 101 studies , 2010, The Lancet.
[39] V. Salomaa,et al. C-reactive protein-associated genetic variants and cancer risk: findings from FINRISK 1992, FINRISK 1997 and Health 2000 studies. , 2011, European journal of cancer.
[40] E. Silverman,et al. Polymorphisms in surfactant protein-D are associated with chronic obstructive pulmonary disease. , 2011, American journal of respiratory cell and molecular biology.
[41] N. Sattar,et al. Replication of LDL GWAs hits in PROSPER/PHASE as validation for future (pharmaco)genetic analyses , 2011, BMC Medical Genetics.
[42] Fred A. Wright,et al. Genome-wide association and linkage identify modifier loci of lung disease severity in cystic fibrosis at 11p13 and 20q13.2 , 2011, Nature Genetics.
[43] Taesung Park,et al. Large-scale genome-wide association studies in east Asians identify new genetic loci influencing metabolic traits , 2011, Nature Genetics.
[44] Bartolome Celli,et al. Induced sputum genes associated with spirometric and radiological disease severity in COPD ex-smokers , 2011, Thorax.
[45] M. Elmlinger,et al. Comprehensive characterisation of pulmonary and serum surfactant protein D in COPD , 2011, Respiratory research.
[46] J. Vestbo,et al. Determinants of depression in the ECLIPSE chronic obstructive pulmonary disease cohort. , 2011, American journal of respiratory and critical care medicine.
[47] T. Beaty,et al. Genetics of Sputum Gene Expression in Chronic Obstructive Pulmonary Disease , 2011, PloS one.
[48] C. Gieger,et al. A genome-wide association study identifies novel loci associated with circulating IGF-I and IGFBP-3. , 2011, Human molecular genetics.
[49] H. Lin,et al. Association between psoriasis and chronic obstructive pulmonary disease: a population‐based study in Taiwan , 2012, Journal of the European Academy of Dermatology and Venereology : JEADV.
[50] L. Edwards,et al. Inflammatory biomarkers improve clinical prediction of mortality in chronic obstructive pulmonary disease. , 2012, American journal of respiratory and critical care medicine.
[51] L. Edwards,et al. A genome-wide association study of COPD identifies a susceptibility locus on chromosome 19q13. , 2012, Human molecular genetics.
[52] Courtney Crim,et al. Persistent Systemic Inflammation is Associated with Poor Clinical Outcomes in COPD: A Novel Phenotype , 2012, PloS one.
[53] F. Martinez,et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. , 2007, American journal of respiratory and critical care medicine.